Market Context
New Jersey link building: a dense suburban market with pharma, finance, and proximity to New York authority.
New Jersey's publishing ecosystem benefits from its position between the New York and Philadelphia markets, hosting significant pharmaceutical, finance, and legal industry coverage that national link buyers frequently overlook in favor of costlier NYC placements.
New Jersey's primary publications include NJ.com (Advance Local), the Bergen Record, the Asbury Park Press, and NJBIZ (New Jersey's leading business journal). Pharmaceutical industry coverage is particularly strong, reflecting the Route 1 Corridor's density of major pharma headquarters. Princeton and Rutgers-adjacent academic publishing adds credible research-backed editorial coverage.
DR ranges for New Jersey publishers typically sit between DR 45-70 for major outlets, with NJBIZ and NJ.com anchoring the upper range. Pricing reflects an accessible mid-market — placements often deliver stronger ROI than equivalent NYC options at 30-40% lower cost, with audiences that include significant NJ-based corporate decision-makers.
New Jersey's distinct link building advantage is its pharma and healthcare publishing density. Brands building topical authority in pharmaceuticals, clinical research, healthcare compliance, and life sciences will find NJ publishers uniquely well-positioned editorially. Finance, insurance, and logistics are secondary strengths given the state's corporate infrastructure.
Key verticals: pharmaceuticals and clinical research, healthcare and hospital systems, finance and insurance, logistics and warehousing, legal services, and suburban retail and real estate.